TCON — TRACON Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $0.15m
- -$6.12m
- $12.05m
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants
Brief: TRACON Pharmaceuticals Announces Reverse Stock Split
Brief: TRACON Pharmaceuticals Provides Update On Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation To Continue Trial As Planned
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In December: Earnings Summary
Brief: TRACON Pharmaceuticals Q4 Net Income USD 439 Thousand
Tracon Pharmaceuticals Inc Expected To Post A Loss Of 8 Cents A Share: Earnings Preview
U.S. STOCKS ON THE MOVE-Coinbase Global, Spirit AeroSystems, Crown Castle
U.S. STOCKS ON THE MOVE-Toro, TRACON Pharma, Fulton Financial
TRACON Pharma rises on positive trial results for cancer drug
Brief: Tracon Pharmaceuticals Provides Positive Update On Ongoing Envasarc Pivotal Phase 2 Trial
Brief: Tracon Pharmaceuticals Submits Request For Appeal Hearing Before Nasdaq Panel
Brief: TRACON Pharmaceuticals Announces License of Product Development Platform for $3 Mln
Brief: TRACON Pharmaceuticals Q3 Net Income USD 10.763 Million
U.S. RESEARCH ROUNDUP-Acushnet Holdings, Sarcos Technology and Robotics, Tracon Pharmaceuticals
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In June: Earnings Summary